These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7629802)

  • 1. Structure-activity relationships for inhibition of type 1 and 2 human 5 alpha-reductase and human adrenal 3 beta-hydroxy-delta 5-steroid dehydrogenase/3-keto-delta 5-steroid isomerase by 6-azaandrost-4-en-3-ones: optimization of the C17 substituent.
    Frye SV; Haffner CD; Maloney PR; Hiner RN; Dorsey GF; Noe RA; Unwalla RJ; Batchelor KW; Bramson HN; Stuart JD
    J Med Chem; 1995 Jul; 38(14):2621-7. PubMed ID: 7629802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-Azasteroids: structure-activity relationships for inhibition of type 1 and 2 human 5 alpha-reductase and human adrenal 3 beta-hydroxy-delta 5-steroid dehydrogenase/3-keto-delta 5-steroid isomerase.
    Frye SV; Haffner CD; Maloney PR; Mook RA; Dorsey GF; Hiner RN; Cribbs CM; Wheeler TN; Ray JA; Andrews RC
    J Med Chem; 1994 Jul; 37(15):2352-60. PubMed ID: 8057283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3 Beta-hydroxy-delta 5-steroid dehydrogenase/3-keto-delta 5-steroid isomerase from bovine adrenals: mechanism of inhibition by 3-oxo-4-aza steroids and kinetic mechanism of the dehydrogenase.
    Brandt M; Levy MA
    Biochemistry; 1989 Jan; 28(1):140-8. PubMed ID: 2706240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Methyl-3-oxo-4-aza-5alpha-androst-1-ene-17beta-N-aryl-carboxamides: an approach to combined androgen blockade [5alpha-reductase inhibition with androgen receptor binding in vitro].
    Tolman RL; Sahoo SP; Bakshi RK; Gratale D; Patel G; Patel S; Toney J; Chang B; Harris GS
    J Steroid Biochem Mol Biol; 1997 Mar; 60(5-6):303-9. PubMed ID: 9219921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linear relationships between the ligand binding energy and the activation energy of time-dependent inhibition of steroid 5alpha-reductase by delta 1-4-azasteroids.
    Tian G; Haffner CD
    J Biol Chem; 2001 Jun; 276(24):21359-64. PubMed ID: 11279132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human adrenal steroidogenic enzymes in vitro by imidazole drugs including ketoconazole.
    Ayub M; Levell MJ
    J Steroid Biochem; 1989 Apr; 32(4):515-24. PubMed ID: 2724954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of synthetic progestins, 4-MA and cyanoketone on human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene-isomerase activity.
    Takahashi M; Luu-The V; Labrie F
    J Steroid Biochem Mol Biol; 1990 Oct; 37(2):231-6. PubMed ID: 2268554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSARs for 6-azasteroids as inhibitors of human type 1 5alpha-reductase: prediction of binding affinity and selectivity relative to 3-BHSD.
    Bakken GA; Jurs PC
    J Chem Inf Comput Sci; 2001; 41(5):1255-65. PubMed ID: 11604025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism based representation of the active site of 5 alpha-reductase (5AR).
    Ahmed S; Denison S
    Bioorg Med Chem Lett; 1998 Sep; 8(18):2615-70. PubMed ID: 9873591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine properties of the testosterone 5 alpha-reductase inhibitor turosteride (FCE 26073).
    Di Salle E; Briatico G; Giudici D; Ornati G; Panzeri A
    J Steroid Biochem Mol Biol; 1994 Feb; 48(2-3):241-8. PubMed ID: 8142301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique preclinical characteristics of GG745, a potent dual inhibitor of 5AR.
    Bramson HN; Hermann D; Batchelor KW; Lee FW; James MK; Frye SV
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1496-502. PubMed ID: 9316864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5alpha-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat.
    Stuart JD; Lee FW; Simpson Noel D; Kadwell SH; Overton LK; Hoffman CR; Kost TA; Tippin TK; Yeager RL; Batchelor KW; Bramson HN
    Biochem Pharmacol; 2001 Oct; 62(7):933-42. PubMed ID: 11543729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the M. tuberculosis 3β-hydroxysteroid dehydrogenase by azasteroids.
    Thomas ST; Yang X; Sampson NS
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2216-9. PubMed ID: 21439822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delta 5-3 beta-hydroxysteroid dehydrogenase-isomerase activity in two distinct density Leydig cells from immature rats. Differences in responsiveness to human chorionic gonadotropin or 8-bromoadenosine 3',5'-monophosphate.
    Murono EP; Washburn AL
    Biochim Biophys Acta; 1991 Jan; 1091(1):55-62. PubMed ID: 1847300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity labeling of human placental 3 beta-hydroxy-delta 5-steroid dehydrogenase and steroid delta-isomerase: evidence for bifunctional catalysis by a different conformation of the same protein for each enzyme activity.
    Thomas JL; Strickler RC; Myers RP; Covey DF
    Biochemistry; 1992 Jun; 31(24):5522-7. PubMed ID: 1610797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure, function and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues.
    Labrie F; Simard J; Luu-The V; Bélanger A; Pelletier G
    J Steroid Biochem Mol Biol; 1992 Dec; 43(8):805-26. PubMed ID: 22217825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and expression of a new complementary DNA encoding the almost exclusive 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase in human adrenals and gonads.
    Rhéaume E; Lachance Y; Zhao HF; Breton N; Dumont M; de Launoit Y; Trudel C; Luu-The V; Simard J; Labrie F
    Mol Endocrinol; 1991 Aug; 5(8):1147-57. PubMed ID: 1944309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azasteroids: structure-activity relationships for inhibition of 5 alpha-reductase and of androgen receptor binding.
    Rasmusson GH; Reynolds GF; Steinberg NG; Walton E; Patel GF; Liang T; Cascieri MA; Cheung AH; Brooks JR; Berman C
    J Med Chem; 1986 Nov; 29(11):2298-315. PubMed ID: 3783591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
    Hirsch KS; Jones CD; Audia JE; Andersson S; McQuaid L; Stamm NB; Neubauer BL; Pennington P; Toomey RE; Russell DW
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5277-81. PubMed ID: 8389478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of human adrenal C17-20 lyase and C19-5-ene, 3beta-hydroxysteroid dehydrogenase.
    Yates J; Deshpande N; Goldman AS
    J Steroid Biochem; 1975 Sep; 6(9):1325-7. PubMed ID: 1181487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.